Gregory M Weinhoff's Net Worth

$4.07 Million

Estimate Recalculated Nov 8, 2024 09:35PM EST

Who is Gregory M Weinhoff

Gregory M Weinhoff has an estimated net worth of $4.07 Million. This is based on reported shares across multiple companies, which include Centessa Pharmaceuticals plc, AMICUS THERAPEUTICS INC, and Axovant Sciences Ltd..

SEC CIK

Gregory M Weinhoff's CIK is 0001400975

Past Insider Trading and Trends

2018 was Gregory M Weinhoff's most active year for acquiring shares with 2 total transactions. Gregory M Weinhoff's most active month to acquire stocks was the month of January. 2024 was Gregory M Weinhoff's most active year for disposing of shares, totalling 5 transactions. Gregory M Weinhoff's most active month to dispose stocks was the month of August. 2021 saw Gregory M Weinhoff paying a total of $200,000.00 for 968,981 shares, this is the most they've acquired in one year. In 2024 Gregory M Weinhoff cashed out on 64,978 shares for a total of $700,072.78, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Centessa Pharmaceuticals plc

Chief Business Officer
Updated Oct 25, 2024
Form 4
-6.02%
-11.74K
$15.38
-$180.63K
Oct 25, 2024
183.27K
Sale
ScheduledOct 25
Form 4
-3.58%
-30.00K
$11.42
-$334.80K
Sep 12, 2024
807.69K
Sale
ScheduledSep 10
Form 4
-2.90%
-25.00K
$10.42
-$229.00K
Sep 09, 2024
837.69K
Sale
ScheduledSep 09
Form 4
-11.84%
-30.00K
$12.24
-$367.22K
Aug 23, 2024
223.37K
Sale
ScheduledAug 22 - Aug 23
Form 4
-4.43%
-11.74K
$9.03
-$106.03K
Jul 02, 2024
253.37K
Tax
Jun 30
Form 4
-4.24%
-11.74K
$11.30
-$132.68K
Apr 02, 2024
265.11K
Tax
Mar 31
Form 4
56.30%
144.76K
$8.19
-$94.14K
Feb 02, 2024
401.85K
Grant
Feb 01
Form 4
-4.37%
-11.74K
$7.96
-$93.47K
Jan 02, 2024
257.10K
Tax
Dec 31
Form 4
-4.18%
-11.74K
$6.47
-$75.97K
Oct 03, 2023
268.84K
Tax
Sep 30
Form 4
-4.02%
-11.74K
$5.90
-$69.28K
Jul 03, 2023
280.58K
Tax
Jun 30
Form 4
-2.76%
-8.29K
$3.90
-$32.34K
Apr 04, 2023
292.32K
Tax
Mar 31
Form 4
86.03%
192.20K
Feb 03, 2023
415.62K
Grant
Feb 01
Form 4
-4.70%
-11.28K
$4.25
-$47.95K
Jan 13, 2023
228.72K
Tax
Sep 30
Form 4
-2.21%
-5.30K
$3.10
-$16.44K
Jan 04, 2023
234.70K
Tax
Dec 31
Form 4/A
Nov 23, 2022
240.00K
Form 4
-3.71%
-8.90K
$4.00
-$35.63K
Oct 04, 2022
231.10K
Sale
Sep 30 - Oct 03
Form 4
2,300.00%
230.00K
Jul 06, 2022
240.00K
Grant
Jul 01
Form 4
230.00K
Feb 03, 2022
230.00K
Grant
Feb 01
Form 4
968.98K
$20.00
$200.00K
Jun 04, 2021
968.98K
Purchase
Mar 04 - Jun 02
Form 3/A
Jun 04, 2021
Form 3
May 27, 2021
Showing 21 results

AMICUS THERAPEUTICS INC

Investor
Updated Aug 18, 2008
Form 4
-2.37%
-50.00K
$17.00
-$850.00K
Aug 18, 2008
2.06M
Sale
Aug 14
Form 4
10.00K
Jun 12, 2008
10.00K
Grant
Jun 10
Form 4
0.00%
70.00
Jun 07, 2007
2.11M
Options
Jun 05
Form 3
May 30, 2007
133.33K
Showing 4 results

Axovant Sciences Ltd.

Principal Financial Officer
Updated Mar 16, 2018
Form 4
1.15M
Mar 16, 2018
1.15M
Grant
Mar 15
Form 4
175.00K
May 02, 2017
629.10K
Grant
Apr 28
Form 4
200.00K
May 03, 2016
200.00K
Grant
Apr 29
Form 4
454.10K
Sep 17, 2015
454.10K
Grant
Sep 15
Form 3
Aug 18, 2015
Showing 5 results